Status:
COMPLETED
Trifecta Achievement in Open and Laparoscopic Partial Nephrectomy
Lead Sponsor:
South Valley University
Conditions:
Trifecta Achievement
Pentafecta Achievement
Eligibility:
All Genders
Phase:
NA
Brief Summary
Background: Partial nephrectomy (PN) is a reference standard for the management of the cT1 renal mass, primarily due to better preservation of renal function. The aim of this work was to determine tri...
Detailed Description
Methods: This prospective, randomized study was carried out on 35 patients with clinical T1 N0M0 renal tumors. Patients were divided into two groups: Group A (n=38): underwent OPN and group B (n=32): ...
Eligibility Criteria
Inclusion
- • Patients who are fit for surgery.
- Patients with renal tumor who are indicated for partial nephrectomy
- Absolute:
- Solitary kidney.
- Bilateral renal tumor.
- CDK.
- Relative:
- Abnormal contralateral kidney (nephropathy, nephrolithiasis, trauma).
- Metabolic disease associated with renal failure (DM, hypertension).
- Genetic syndrome with tumor multifocality (VHL syndrome). Elective
- 1\. Clinical T1N0M0 Tumor. 2. Peripheral tumor.
Exclusion
- • Patients who are unfit for surgery and who's unfit for laparoscopy.
- Patients who are contraindicated for partial nephrectomy. As severe and irreversible coagulopathy. Patients who are indicated for radical nephrectomy (extensive tumor, metastatic tumor).
Key Trial Info
Start Date :
June 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2025
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT06960135
Start Date
June 1 2022
End Date
March 1 2025
Last Update
May 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
SVU hospital
Qena, Egypt, Qena Governorate, Egypt, 83511